BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36717026)

  • 1. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.
    Falkevall A; Mehlem A; Folestad E; Ning FC; Osorio-Conles Ó; Radmann R; de Hollanda A; Wright SD; Scotney P; Nash A; Eriksson U
    J Hepatol; 2023 May; 78(5):901-913. PubMed ID: 36717026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice.
    Sakane S; Hikita H; Shirai K; Myojin Y; Sasaki Y; Kudo S; Fukumoto K; Mizutani N; Tahata Y; Makino Y; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1683-1699. PubMed ID: 34303881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue-liver crosstalk during pathologic changes caused by vinyl chloride metabolites in mice.
    Kaelin BR; McKenzie CM; Hempel KW; Lang AL; Arteel GE; Beier JI
    Toxicol Appl Pharmacol; 2020 Jul; 399():115068. PubMed ID: 32445754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y13 receptor deficiency favors adipose tissue lipolysis and worsens insulin resistance and fatty liver disease.
    Duparc T; Gore E; Combes G; Beuzelin D; Pires Da Silva J; Bouguetoch V; Marquès MA; Velazquez A; Viguerie N; Tavernier G; Arner P; Rydén M; Langin D; Sioufi N; Nasser M; Cabou C; Najib S; Martinez LO
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38470490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity.
    Mulder P; Morrison MC; Wielinga PY; van Duyvenvoorde W; Kooistra T; Kleemann R
    Int J Obes (Lond); 2016 Apr; 40(4):675-84. PubMed ID: 26499443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of metformin with morin alleviates hepatic steatosis via modulating hepatic lipid metabolism, hepatic inflammation, brown adipose tissue thermogenesis, and white adipose tissue browning in high-fat diet-fed mice.
    Tehrani SS; Goodarzi G; Panahi G; Zamani-Garmsiri F; Meshkani R
    Life Sci; 2023 Jun; 323():121706. PubMed ID: 37075944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
    Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
    Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance.
    Camporez JP; Lyu K; Goldberg EL; Zhang D; Cline GW; Jurczak MJ; Dixit VD; Petersen KF; Shulman GI
    J Physiol; 2019 Aug; 597(15):3885-3903. PubMed ID: 31206703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model.
    Lee SB; Kim HG; Lee JS; Kim WY; Lee MM; Kim YH; Lee JO; Kim HS; Son CG
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G811-G823. PubMed ID: 31604029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
    Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
    J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice.
    Ceddia RP; Lee D; Maulis MF; Carboneau BA; Threadgill DW; Poffenberger G; Milne G; Boyd KL; Powers AC; McGuinness OP; Gannon M; Breyer RM
    Endocrinology; 2016 Jan; 157(1):220-32. PubMed ID: 26485614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
    Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
    Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis.
    An YA; Chen S; Deng Y; Wang ZV; Funcke JB; Shah M; Shan B; Gordillo R; Yoshino J; Klein S; Kusminski CM; Scherer PE
    J Hepatol; 2021 Aug; 75(2):387-399. PubMed ID: 33746082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice.
    Cruz MM; Simão JJ; de Sá RDCC; Farias TSM; da Silva VS; Abdala F; Antraco VJ; Armelin-Correa L; Alonso-Vale MIC
    Front Endocrinol (Lausanne); 2020; 11():537061. PubMed ID: 33117273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.
    van den Hoek AM; de Jong JCBC; Worms N; van Nieuwkoop A; Voskuilen M; Menke AL; Lek S; Caspers MPM; Verschuren L; Kleemann R
    Metabolism; 2021 Nov; 124():154873. PubMed ID: 34478753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte-specific Hypoxia-inducible gene 2 promotes fat deposition and diet-induced insulin resistance.
    DiStefano MT; Roth Flach RJ; Senol-Cosar O; Danai LV; Virbasius JV; Nicoloro SM; Straubhaar J; Dagdeviren S; Wabitsch M; Gupta OT; Kim JK; Czech MP
    Mol Metab; 2016 Dec; 5(12):1149-1161. PubMed ID: 27900258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.